These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 9424017)

  • 1. Novel NMDA/glycine site antagonists attenuate cocaine-induced behavioral toxicity.
    Matsumoto RR; Brackett RL; Kanthasamy AG
    Eur J Pharmacol; 1997 Nov; 338(3):233-42. PubMed ID: 9424017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of AMPA/kainate glutamate receptor antagonists on cocaine-induced convulsions and lethality in mice.
    Pouw B; Nour M; Matsumoto RR
    Eur J Pharmacol; 1999 Dec; 386(2-3):181-6. PubMed ID: 10618468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cocaine-induced convulsions and lethality in mice: effectiveness of targeting different sites on the NMDA receptor complex.
    Brackett RL; Pouw B; Blyden JF; Nour M; Matsumoto RR
    Neuropharmacology; 2000 Jan; 39(3):407-18. PubMed ID: 10698007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACEA-1328, an NMDA receptor antagonist, increases the potency of morphine and U50,488H in the tail flick test in mice.
    Lutfy K; Doan P; Nugyen M; Weber E
    Pharmacol Res; 1998 Dec; 38(6):453-60. PubMed ID: 9990654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine site antagonist.
    Ilyin VI; Whittemore ER; Tran M; Shen KZ; Cai SX; Kher SM; Keana JF; Weber E; Woodward RM
    Eur J Pharmacol; 1996 Aug; 310(2-3):107-14. PubMed ID: 8884205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of nociceptive responses by ACEA-1021, a competitive NMDA receptor/glycine site antagonist, in the mice.
    Lutfy K; Weber E
    Brain Res; 1996 Dec; 743(1-2):17-23. PubMed ID: 9017225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
    Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
    Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ACEA-1328, a NMDA receptor/glycine site antagonist, on U50,488H-induced antinociception and tolerance.
    Lutfy K; Doan P; Nguyen M; Weber E
    Eur J Pharmacol; 1999 Nov; 384(1):1-5. PubMed ID: 10611412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reevaluation of ACEA 1021 as an antagonist at the strychnine-insensitive glycine site of the N-methyl-D-aspartate receptor.
    Lingenhöhl K; Pozza MF
    Neuropharmacology; 1998 Jun; 37(6):729-37. PubMed ID: 9707286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia.
    Hicks CA; Ward MA; Ragumoorthy N; Ambler SJ; Dell CP; Dobson D; O'Neill MJ
    Brain Res; 1999 Feb; 819(1-2):65-74. PubMed ID: 10082862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
    Nishiyama T
    Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds.
    Cai SX
    Curr Top Med Chem; 2006; 6(7):651-62. PubMed ID: 16719807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist.
    Lutfy K; Shen KZ; Kwon IS; Cai SX; Woodward RM; Keana JF; Weber E
    Eur J Pharmacol; 1995 Jan; 273(1-2):187-9. PubMed ID: 7737313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CNQX but not NBQX prevents expression of amphetamine-induced place preference conditioning: a role for the glycine site of the NMDA receptor, but not AMPA receptors.
    Mead AN; Stephens DN
    J Pharmacol Exp Ther; 1999 Jul; 290(1):9-15. PubMed ID: 10381753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
    Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E
    Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice.
    Wiley JL; Cristello AF; Balster RL
    Eur J Pharmacol; 1995 Dec; 294(1):101-7. PubMed ID: 8788421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
    Lutfy K; Doan P; Weber E
    Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats.
    Kretschmer BD; Kratzer U; Breithecker K; Koch M
    Eur J Pharmacol; 1997 Jul; 331(2-3):109-16. PubMed ID: 9274968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant efficacy of N-methyl-D-aspartate antagonists against convulsions induced by cocaine.
    Witkin JM; Gasior M; Heifets B; Tortella FC
    J Pharmacol Exp Ther; 1999 May; 289(2):703-11. PubMed ID: 10215643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.